| All patients | Training group | Validation group | P value |
---|---|---|---|---|
Patient number | 345 | 173 | 172 | Â |
Median age (range), years | 26 (2–58) | 26 (4–58) | 26 (2–58) | 0.830 |
Median weight (range), kg | 62 (13–113) | 61 (18–113) | 63 (13–110) | 0.388 |
Male sex, n (%) | 201 (58.3) | 100 (57.8) | 101 (58.7) | 0.863 |
Diagnosis, n (%) | Â | Â | Â | 0.142 |
 AML | 137 (39.7) | 69 (39.9) | 68 (39.5) |  |
 ALL | 116 (33.6) | 49 (28.3) | 67 (39.0) |  |
 CML | 19 (5.5) | 10 (5.8) | 9 (5.2) |  |
 MDS | 38 (11.0) | 24 (13.9) | 14 (8.1) |  |
 Others | 35 (10.1) | 21 (12.1) | 14 (8.1) |  |
Disease status, SR/HR (n (%)) | 265 (76.8)/80 (23.2) | 135 (78.0)/38 (22.0) | 135 (78.0)/38 (22.0) | 0.589 |
Conditioning regimen | Â | Â | Â | Â |
 MA | 345 (100 %) | 173 (100 %) | 172 (100 %) |  |
No of HLA-A, B, DR mismatched | Â | Â | Â | 0.302 |
 0 | 2 (0.6 %) | 1 (0.6 %) | 1 (0.6 %) |  |
 1 | 18 (5.2 %) | 13 (7.5 %) | 5 (2.9 %) |  |
 2 | 74 (21.4 %) | 34 (19.7) | 40 (23.3 %) |  |
 3 | 249 (72.2 %) | 124 (71.1 %) | 125 (72.2 %) |  |
Donor-recipient sex match, n (%) | Â | Â | Â | 0.609 |
 Male-male | 132 (38.3) | 63 (36.4) | 69 (40.1) |  |
 Male-female | 89 (25.8) | 42 (24.3) | 47 (27.3) |  |
 Female-male | 71 (20.6) | 38 (22.0) | 33 (19.2) |  |
 Female-female | 53 (15.4) | 30 (17.3) | 23 (13.4) |  |
Donor-recipient relationship, n (%) | Â | Â | Â | 0.419 |
 Father-child | 134 (38.8) | 64 (37.0) | 70 (40.7) |  |
 Mother-child | 45 (13.0) | 28 (16.2) | 17 (9.9) |  |
 Sibling-sibling | 103 (29.9) | 53 (30.6) | 50 (29.1) |  |
 Child-parent | 53 (15.4) | 25 (14.5) | 28 (16.3) |  |
 Other | 10 (2.9) | 3 (1.7) | 7 (4.1) |  |
ABO matched, n (%) | Â | Â | Â | 0.345 |
 Matched | 196 (56.8) | 102 (59.2) | 94 (54.7) |  |
 Major mismatched | 64 (18.6) | 34 (19.7) | 30 (17.4) |  |
 Minor mismatched | 18 (5.2) | 10 (5.8) | 8 (4.7) |  |
 Bidirect mismatched | 67 (19.4) | 27 (15.6) | 40 (23.3) |  |
Cell compositions in allografts | Â | Â | Â | Â |
 Infused nuclear cells 108/kg | 8.34 (1.78–23.69) | 8.32 (1.78–23.59) | 8.40 (2.12–23.69) | 0.321 |
 Infused CD34+ cells 106/kg | 2.59 (0.39–16.82) | 2.71 (0.39–14.47) | 2.49 (0.58–16.82) | 0.840 |
 Infused lymphocytes 108/kg | 2.95 (0.16–9.49) | 2.88 (0.16–9.49) | 3.06 (0.68–7.34) | 0.107 |
 Infused CD3+ cells 108/kg | 2.00 (0.10–5.93) | 2.00 (0.10–5.93) | 1.99 (0.20–5.36) | 0.575 |
 Infused CD4+ cells 108/kg | 1.10 (0.10–3.94) | 1.09 (0.10–3.33) | 1.13 (0.19–3.94) | 0.371 |
 Infused CD8+ cells 108/kg | 0.70 (0.05–2.47) | 0.69 (0.05–2.47) | 0.72 (0.14–2.43) | 0.452 |
 Infused CD14+ cells 108/kg | 1.49 (0.05–4.90) | 1.50 (0.33–4.90) | 1.48 (0.05–6.13) | 0.769 |